These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18443106)

  • 1. In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: microbiology profiling studies with staphylococci and streptococci.
    Robertson GT; Bonventre EJ; Doyle TB; Du Q; Duncan L; Morris TW; Roche ED; Yan D; Lynch AS
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2324-34. PubMed ID: 18443106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus.
    Robertson GT; Bonventre EJ; Doyle TB; Du Q; Duncan L; Morris TW; Roche ED; Yan D; Lynch AS
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2313-23. PubMed ID: 18443108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of the new quinolone WCK 771 against staphylococci.
    Jacobs MR; Bajaksouzian S; Windau A; Appelbaum PC; Patel MV; Gupte SV; Bhagwat SS; De Souza NJ; Khorakiwala HF
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3338-42. PubMed ID: 15328094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifamycin resistance, rpoB gene mutation and clinical outcomes of Staphylococcus species isolates from prosthetic joint infections in Republic of Korea.
    Lee Y; Kim SS; Choi SM; Bae CJ; Oh TH; Kim SE; Kim UJ; Kang SJ; Jung SI; Park KH
    J Glob Antimicrob Resist; 2022 Mar; 28():43-48. PubMed ID: 34920175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
    Karlowsky JA; Adam HJ; Poutanen SM; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):342-7. PubMed ID: 21353963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
    Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of novel rifamycins against gram-positive clinical isolates.
    Murphy CK; Karginova E; Sahm D; Rothstein DM
    J Antibiot (Tokyo); 2007 Sep; 60(9):572-6. PubMed ID: 17917240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-methicillin-resistant Staphylococcus aureus quinolone WCK 771 has potent activity against sequentially selected mutants, has a narrow mutant selection window against quinolone-resistant Staphylococcus aureus, and preferentially targets DNA gyrase.
    Bhagwat SS; Mundkur LA; Gupte SV; Patel MV; Khorakiwala HF
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3568-79. PubMed ID: 16940059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifamycin Derivatives Are Effective Against Staphylococcal Biofilms In Vitro and Elutable From PMMA.
    Sanchez CJ; Shiels SM; Tennent DJ; Hardy SK; Murray CK; Wenke JC
    Clin Orthop Relat Res; 2015 Sep; 473(9):2874-84. PubMed ID: 25896136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal activity of ACH-702 against nondividing and biofilm Staphylococci.
    Podos SD; Thanassi JA; Leggio M; Pucci MJ
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3812-8. PubMed ID: 22547614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postantibiotic effect and postantibiotic sub-minimum inhibitory concentration effect of valnemulin against Staphylococcus aureus isolates from swine and chickens.
    Zhao DH; Yu Y; Zhou YF; Shi W; Deng H; Liu YH
    Lett Appl Microbiol; 2014 Feb; 58(2):150-5. PubMed ID: 24117872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gepotidacin (GSK2140944)
    Flamm RK; Farrell DJ; Rhomberg PR; Scangarella-Oman NE; Sader HS
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative activity of ozenoxacin and other quinolones in Staphylococcus aureus strains overexpressing the efflux pump-encoding genes mepA and norA.
    López Y; Tato M; Gargallo-Viola D; Cantón R; Vila J; Zsolt I
    Int J Antimicrob Agents; 2020 Sep; 56(3):106082. PubMed ID: 32659467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro studies of the pharmacodynamics of teicoplanin against Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium.
    Odenholt I; Löwdin E; Cars O
    Clin Microbiol Infect; 2003 Sep; 9(9):930-7. PubMed ID: 14616681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis.
    Löwdin E; Odenholt I; Cars O
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2739-44. PubMed ID: 9756787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of TNP-2092 against periprosthetic joint infection-associated staphylococci.
    Fisher CR; Schmidt-Malan SM; Ma Z; Yuan Y; He S; Patel R
    Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115040. PubMed ID: 32354459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postantibiotic effect and postantibiotic sub-MIC effect of LTX-109 and mupirocin on Staphylococcus aureus blood isolates.
    Saravolatz LD; Pawlak J; Martin H; Saravolatz S; Johnson L; Wold H; Husbyn M; Olsen WM
    Lett Appl Microbiol; 2017 Nov; 65(5):410-413. PubMed ID: 28802058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telithromycin post-antibiotic and post-antibiotic sub-MIC effects for 10 Gram-positive cocci.
    Jacobs MR; Bajaksouzian S; Appelbaum PC
    J Antimicrob Chemother; 2003 Nov; 52(5):809-12. PubMed ID: 14519674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci.
    Dixson S; Brumfitt W; Hamilton-Miller JM
    Eur J Clin Microbiol; 1985 Feb; 4(1):19-23. PubMed ID: 3157567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.